Product image of Naloxone Aguettant (Anhydrous Naloxone Hydrochloride) supplied by GNH India

Naloxone Aguettant

Active Ingredient:
Anhydrous Naloxone Hydrochloride
Origin:
EU

Naloxone Aguettant (Anhydrous Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone Aguettant, is an opioid antagonist presented as a sterile solution for intramuscular, intravenous, or subcutaneous use. It rapidly reverses opioid‑induced respiratory depression and other life‑threatening effects of opioid overdose in emergency settings.

GNH India supplies Naloxone Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable delivery across global markets.

Manufacturer / TM Owner

Laboratoire Aguettant

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Naloxone is an opioid antagonist used in the management of opioid overdose and related respiratory depression.

  • Opioid overdose: rapidly restores normal breathing and consciousness.
  • Opioid‑induced respiratory depression: reverses respiratory suppression caused by opioid analgesics.
  • Acute opioid toxicity: counteracts life‑threatening effects of opioid toxicity in emergency care.

How It Works

  • Naloxone competitively binds to mu, kappa and delta opioid receptors without activating them, displacing opioid agonists and thereby blocking their pharmacologic effects. This antagonism quickly reverses opioid‑mediated central nervous system depression, restoring respiratory drive and consciousness in patients experiencing opioid toxicity.

Side Effects

Naloxone may cause a range of adverse reactions, most of which are related to its rapid reversal of opioid effects.

Common Side Effects

  • Nausea: mild to moderate nausea may occur.
  • Vomiting: occasional vomiting after administration.
  • Sweating: increased perspiration.
  • Agitation: transient restlessness or anxiety.

Serious or Rare Side Effects

  • Cardiac arrhythmia: rare irregular heart rhythms.
  • Seizure: infrequent seizures in susceptible individuals.
  • Pulmonary edema: rare fluid accumulation in the lungs.
  • Hypertension: sudden high blood pressure.

Precautions & Warnings

Naloxone should be used with careful clinical assessment and monitoring.

  • Assess patient: confirm opioid overdose before administration.
  • Monitor vital signs: observe respiratory rate, heart rate, and blood pressure after dosing.
  • Re‑dose if needed: be prepared to repeat naloxone if opioid effect persists.
  • Consider underlying conditions: patients with cardiovascular disease may experience tachycardia.
  • Avoid in hypersensitivity: do not use if known allergy to naloxone or formulation components.
  • Store at ambient temperature: keep below 25°C, protect from moisture and light, retain in original packaging.

Avoid Interactions

Naloxone may interact with other medications that affect the central nervous system or cardiovascular function.

Major Interactions (Avoid)

  • Opioid agonists: concurrent high‑dose opioids may diminish naloxone effect, requiring higher doses.
  • Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis when combined with naloxone.

Moderate Interactions (Monitor Closely)

  • Benzodiazepines: may mask withdrawal symptoms after naloxone reversal.
  • Tricyclic antidepressants: potential for additive cardiovascular effects.
  • Alcohol: may exacerbate central nervous system stimulation.

Frequently Asked Questions

Naloxone Aguettant is used to rapidly reverse the effects of opioid overdose, including life‑threatening respiratory depression, and to treat acute opioid toxicity in emergency medical situations.

Naloxone works by competitively binding to mu, kappa and delta opioid receptors without activating them, displacing opioid molecules and blocking their effects. This antagonism quickly restores normal breathing and consciousness in patients who have received an opioid overdose.

The dose of Naloxone Aguettant is determined by the prescribing clinician based on the severity of opioid exposure, the route of administration, and the patient’s clinical response. Healthcare professionals follow local protocols to decide the initial and any subsequent doses.

Safety data for naloxone in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Naloxone Aguettant, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Naloxone is the most widely used opioid antagonist for emergency reversal because of its rapid onset and short duration of action. Compared with longer‑acting agents such as naltrexone, naloxone is preferred in acute settings where a quick, temporary blockade of opioid effects is needed.

Naloxone Aguettant should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and avoid freezing to maintain stability.

Naloxone Aguettant is supplied as a sterile solution and can be given by intramuscular, intravenous, or subcutaneous injection. The route is chosen by the treating clinician based on the clinical situation and available access.

Serious risks include acute opioid withdrawal, which can cause hypertension, tachycardia, agitation, or seizures, especially in patients with high opioid dependence. Cardiovascular complications such as arrhythmias may also occur and require immediate medical attention.

Naloxone Aguettant should not be used in individuals with a known hypersensitivity to naloxone or any component of the formulation. Caution is advised in patients with severe cardiovascular disease, as rapid reversal can precipitate hemodynamic changes.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Anhydrous Naloxone Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT